...
首页> 外文期刊>International heart journal >General Anesthesia or Conscious Sedation for Transfemoral Aortic Valve Replacement with the SAPIEN 3 Transcatheter Heart Valve
【24h】

General Anesthesia or Conscious Sedation for Transfemoral Aortic Valve Replacement with the SAPIEN 3 Transcatheter Heart Valve

机译:全身麻醉或有意识的镇静粉末与Sapien 3经截管心阀更换的镇静镇静剂

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Differences in the benefits of conscious sedation (CS) and general anesthesia (GA) during transfemoral aortic valve implantation (TAVI) are unclear.We aimed to assess differences in procedural and clinical outcomes based on the type of anesthesia received during TAVI.We analyzed SOURCE 3 Registry data for patients who received the SAPIEN 3 valve by type of anesthesia used during TAVI.Of the 1694 TAVI patients, 1027 received CS and 667 received GA. Patients were similar at baseline (81.5 years; Society of Thoracic Surgeons risk score 7.0). Compared with the GA group, the CS group had fewer intra-procedural transesophageal echocardiography (TEE) and post implantation dilatations performed, and less contrast medium was used. The CS group had significantly less kidney injury at 7 days post-procedure than the GA group (0.4% versus 1.5%, P = 0.014). Moderate paravalvular leaks (PVL) occurred more frequently in the CS group versus the GA group (2.2% versus 0.8%; P = 0.041). No severe PVL were reported. Median total hospital length of stay (LOS) after TAVI was 10 days in the CS group and 11 days in the GS group. At 30 days, all-cause death was 2.1% in CS and 1.7% in GS ( P = 0.47), and myocardial infarction was 0.2% in CS and 0.1% in GS ( P = 0.83).Our analyses found no significant major outcome differences between CS and GA during TAVI.
机译:在经粉末主动脉瓣植入(TAVI)期间有意识镇静(CS)和全身麻醉(GA)的益处的差异尚不清楚。我们旨在评估基于Tavi.we分析的来源的麻醉类型的程序和临床结果的差异3根据Tavi期间使用的麻醉患者接受Sapien 3瓣膜的患者的注册表数据。根据1694塔Tavi患者,1027名收到的CS和667收到GA。患者在基线(81.5岁;胸外科医生的社会风险评分7.0)。与GA组相比,CS组具有较少的程序内经乳膏超声心动图(TEE),并且进行后植入膨胀,使用较少的造影剂。在步骤后7天的肾损伤比GA组(0.4%对1.5%,P = 0.014),CS组显着减少了肾脏损伤。在CS组与GA组中更频繁地发生温和的静脉泄漏(PV1)(2.2%对0.8%; P = 0.041)。没有报告严重的PVL。 Tavi在CS集团的Tavi为10天和GS集团的11天后,中位数总入住时间(LOS)。在30天内,GS的全因死亡为2.1%,GS(P = 0.47)中的1.7%,心肌梗死为0.2%,GS(P = 0.83)中0.1%。我们分析没有显着的主要结果Tavi期间CS和GA之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号